Skip to main content
OpenTrials

Clinical trial condition

Leukemia

Explore clinical trials studying Leukemia. Study availability and eligibility vary by location and protocol.

4,415 public trials 1,033 recruiting studies
Refine in advanced search Browse all conditions

Leukemia trial results

Recruiting

Ivosidenib and Azacitidine With or Without Venetoclax in Adult Patients With Newly Diagnosed IDH1-Mutated AML or MDS/AML Considered Ineligible for Intensive Chemotherapy

NCT07075016

Conditions
Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • AT-Feldkirch-IKHF Feldkirch, Austria
  • AT-Salzburg-SALK Salzburg, Austria
  • AT-Vienna-HANUSCH Vienna, Austria
  • BE-Antwerpen-ZAS Antwerp, Belgium
View all 119 locations
View Trial Details
Recruiting

A Study of GLB-001 in Patients With Myeloid Malignancies

NCT06378437

Conditions
Acute Myeloid Leukemia, Blood Coagulation Disorders, Blood Platelet Disorders, +21 more
Locations
  • The First Affiliated Hospital of University of Science and Technology of China (Anhui Provincial Hospital) Hefei, Anhui, China
  • China-Japan Friendship Hospital Beijing, Beijing Municipality, China
  • The First Affiliated Hospital of Chongqing Medical University Chongqing, Chongqing Municipality, China
  • The First Hospital of Hebei Medical Universtiy Shijiazhuang, Hebei, China
View all 14 locations
View Trial Details
Recruiting

A Phase-3-trial of Acalabrutinib, Obinutuzumab & Venetoclax Compared to Obinutuzumab and Venetoclax in Previously Untreated Patients With High Risk CLL

NCT05197192

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations
  • Helios Klinikum Bad Saarow Bad Saarow, Germany
  • DRK Kliniken Berlin Köpenick Berlin, Germany
  • Ev. Diakoniekrankenhaus Bremen, Germany
  • Universitätsklinik Köln Cologne, Germany
View all 30 locations
View Trial Details
Recruiting

Study to Test OBI-3424 in Patients With T-Cell Acute Lymphoblastic Leukemia (T-ALL) or T-Cell Lymphoblastic Lymphoma (T-LBL)

NCT04315324

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Kingman Regional Medical Center Kingman, Arizona, United States
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • PCR Oncology Arroyo Grande, California, United States
View all 163 locations
View Trial Details
Recruiting

A Study to Evaluate HMPL-306 in Patients With IDH1or IDH2-mutated Acute Myeloid Leukemia

NCT06387069

Conditions
Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • Anhui Provincial Hospital（The First Affiliated Hospital of U STC） Hefei, Anhui, China
  • The First Affiliated Hospital of Anhui Medical University Hefei, Anhui, China
  • The Second Hospital of Anhui Medical University Hefei, Anhui, China
  • Peking University People's Hospital Beijing, Beijing Municipality, China
View all 53 locations
View Trial Details

Related conditions